{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T11:02:49Z","timestamp":1781521369159,"version":"3.54.1"},"reference-count":48,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T00:00:00Z","timestamp":1674345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Treatment-induced cardiac toxicity represents an important issue in non-small cell lung cancer (NSCLC) patients, and no biomarkers are currently available in clinical practice. A novel and easy-to-calculate marker is the quantitative analysis of calcium plaque in the coronary, calculated on CT. It is called the Agatston score (or CAD score). At the same time, other potential predictors include cardiac ultrasonography and anamnesis of the patients. Our work aimed to correlate cardiac biomarkers with overall survival (OS) in NSCLC patients. We retrospectively analyzed patients with NSCLC discussed in the Multidisciplinary Tumor Board of our Institute for the present analysis between January 2018 and July 2022. Inclusion criteria were the availability of basal CT imaging of the thorax, cardiac ultrasonography with the calculation of ejection fraction (EF), and complete anamnesis, including assessment of co-pathologies and pharmacological drugs. The clinical data of the patients were retrospectively collected, and the CAD scores was calculated on a CT scan. All of these parameters were correlated with overall survival (OS) with univariate analysis (Kaplan\u2013Meier analysis) and multivariate analysis (Cox regression analysis). Following the above-mentioned inclusion criteria, 173 patients were included in the present analysis. Of those, 120 patients died in the follow-up period (69.6%), and the median overall survival (OS) was 28 months (mean 47.2 months, 95% CI, 36\u201357 months). In univariate analysis, several parameters that significantly correlated with lower OS were the stage (p &lt; 0.001), the CAD grading (p &lt; 0.001), history of ischemic heart disease (p: 0.034), use of beta blocker drugs (p: 0.036), and cardiac ejection fraction (p: 0.005). In multivariate analysis, the only parameters that remained significant were as follows: CAD score (p: 0.014, OR 1.56, 95% CI: 1.04\u20131.83), stage (p: 0.016, OR: 1.26, 95% CI: 1.05\u20131.53), and cardiac ejection fraction (p: 0.011, OR 0.46, 95% CI: 0.25\u20130.84). Both CAD score and ejection fraction are correlated with survival in NSCLC patients at all stages of the disease. Independently from the treatment choice, a cardiological evaluation is mandatory for patients with NSCLC.<\/jats:p>","DOI":"10.3390\/diagnostics13030400","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T03:48:08Z","timestamp":1674445688000},"page":"400","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Role of Cardiac Biomarkers in Non-Small Cell Lung Cancer Patients"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7347-0965","authenticated-orcid":false,"given":"Valerio","family":"Nardone","sequence":"first","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Reginelli","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"De Marco","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Natale","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Science, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Patan\u00e8","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"De Chiara","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1712-5849","authenticated-orcid":false,"given":"Mauro","family":"Buono","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano Maria","family":"Russo","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Monti","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Balestrucci","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Salvarezza","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Di Guida","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"D\u2019Ippolito","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Sangiovanni","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Grassi","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"D\u2019Onofrio","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"},{"name":"Radiotherapy Unit, Ospedale del Mare, ASL Napoli 1 Centro, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paola","family":"Belfiore","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3802-7052","authenticated-orcid":false,"given":"Giovanni","family":"Cimmino","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Science, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carminia Maria","family":"Della Corte","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Vicidomini","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Science, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0628-613X","authenticated-orcid":false,"given":"Alfonso","family":"Fiorelli","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Science, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4125-0618","authenticated-orcid":false,"given":"Antonio","family":"Gambardella","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriana","family":"Morgillo","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cappabianca","sequence":"additional","affiliation":[{"name":"Department of Precision Medicine, University of Campania \u201cL. Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer Statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA A Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/14737140.2018.1458615","article-title":"The effects of radiotherapy on the survival of patients with unresectable non-small cell lung cancer","volume":"18","author":"Tini","year":"2018","journal-title":"Expert Rev. Anticancer. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"75904","DOI":"10.18632\/oncotarget.20411","article-title":"Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev)","volume":"8","author":"Pastina","year":"2017","journal-title":"Oncotarget"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.21037\/jtd.2017.08.68","article-title":"Anti-cancer activity of dose-fractioned mPE +\/- bevacizumab regimen is paralleled by immune-modulation in advanced squamous NSLC patients","volume":"9","author":"Pastina","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7683648","DOI":"10.1155\/2019\/7683648","article-title":"Looking for Lepidic Component inside Invasive Adenocarcinomas Appearing as CT Solid Solitary Pulmonary Nodules (SPNs): CT Morpho-Densitometric Features and 18-FDG PET Findings","volume":"2019","author":"Reginelli","year":"2019","journal-title":"Biomed. Res. Int."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1200\/JCO.22.00825","article-title":"Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline","volume":"40","author":"Singh","year":"2022","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1200\/JCO.22.00824","article-title":"Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline","volume":"40","author":"Singh","year":"2022","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"684110","DOI":"10.3389\/fonc.2021.684110","article-title":"Inflammatory Markers and Procalcitonin Predict the Outcome of Metastatic Non-Small-Cell-Lung-Cancer Patients Receiving PD-1\/PD-L1 Immune-Checkpoint Blockade","volume":"11","author":"Nardone","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Nardone, V., Giannicola, R., Giannarelli, D., Saladino, R.E., Azzarello, D., Romeo, C., Bianco, G., Rizzo, M.R., Di Meo, I., and Nesci, A. (2021). Distinctive Role of the Systemic Inflammatory Profile in Non-Small-Cell Lung Cancer Younger and Elderly Patients Treated with a PD-1 Immune Checkpoint Blockade: A Real-World Retrospective Multi-Institutional Analysis. Life, 11.","DOI":"10.3390\/life11111235"},{"key":"ref_10","first-page":"1559","article-title":"Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab","volume":"19","author":"Nardone","year":"2020","journal-title":"Oncol. Lett."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12032-020-01375-9","article-title":"The texture analysis as a predictive method in the assessment of the cytological specimen of CT-guided FNAC of the lung cancer","volume":"37","author":"Reginelli","year":"2020","journal-title":"Med. Oncol. (Northwood Lond. Engl.)"},{"key":"ref_12","first-page":"81","article-title":"Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab","volume":"11","author":"Giannicola","year":"2019","journal-title":"Mol. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.2217\/imt-2019-0160","article-title":"Could PD-1\/PDL1 immune checkpoints be linked to HLA signature?","volume":"11","author":"Correale","year":"2019","journal-title":"Immunotherapy"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12032-022-01788-8","article-title":"A critical review on oligometastatic disease: A radiation oncologist\u2019s perspective","volume":"39","author":"Pacifico","year":"2022","journal-title":"Med. Oncol. (Northwood Lond. Engl.)"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/ejcts\/ezab372","article-title":"Significantly favourable outcome for patients with non-small-cell lung cancer stage IIIA\/IIIB and single-station persistent N2 (skip or additionally N1) disease after multimodality treatment","volume":"61","author":"Stamatis","year":"2021","journal-title":"Eur. J. Cardio-Thorac. Surg. Off. J. Eur. Assoc. Cardio-Thorac. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e000846","DOI":"10.1136\/bmjresp-2020-000846","article-title":"Impact on quality of life from multimodality treatment for lung cancer: A randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)","volume":"8","author":"Taylor","year":"2021","journal-title":"BMJ Open Respir. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.21037\/tlcr-20-1210","article-title":"Stage III N2 non-small cell lung cancer treatment: Decision-making among surgeons and radiation oncologists","volume":"10","author":"Glatzer","year":"2021","journal-title":"Transl. Lung Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.lungcan.2021.03.013","article-title":"Trends and variations in treatment of stage I-III non-small cell lung cancer from 2008 to 2018: A nationwide population-based study from the Netherlands","volume":"155","author":"Evers","year":"2021","journal-title":"Lung Cancer (Amst. Neth.)"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.athoracsur.2019.01.071","article-title":"The Optimal Choice of Local Therapy for Stage IIIA-N2 NSCLC: Is Radiotherapy Inferior to Surgery?","volume":"108","author":"Nardone","year":"2019","journal-title":"Ann. Thorac. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4250\/jcvi.2019.27.e38","article-title":"Coronary Artery Dose-Volume Parameters Predict Risk of Calcification After Radiation Therapy","volume":"27","author":"Milgrom","year":"2019","journal-title":"J. Cardiovasc. Imaging"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ctro.2022.02.007","article-title":"Prediction models for treatment-induced cardiac toxicity in patients with non-small-cell lung cancer: A systematic review and meta-analysis","volume":"33","author":"Tohidinezhad","year":"2022","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"908173","DOI":"10.3389\/fimmu.2022.908173","article-title":"Cardiovascular Toxicity With PD-1\/PD-L1 Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Liang, Z., He, Y., and Hu, X. (2022). Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810617"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.diii.2016.06.007","article-title":"CT calcium scoring. History, current status and outlook","volume":"98","author":"Sandfort","year":"2017","journal-title":"Diagn. Interv. Imaging"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4786","DOI":"10.1158\/0008-5472.CAN-18-0125","article-title":"LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumor Heterogeneity","volume":"78","author":"Nioche","year":"2018","journal-title":"Cancer Res."},{"key":"ref_27","first-page":"860","article-title":"Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial","volume":"16","author":"Vicente","year":"2021","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"110140","DOI":"10.1016\/j.ejrad.2021.110140","article-title":"The role of coronary artery calcification score in lung cancer patients","volume":"147","author":"Nardone","year":"2022","journal-title":"Eur. J. Radiol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Reginelli, A., Nardone, V., Giacobbe, G., Belfiore, M.P., Grassi, R., Schettino, F., Del Canto, M., Grassi, R., and Cappabianca, S. (2021). Radiomics as a New Frontier of Imaging for Cancer Prognosis: A Narrative Review. Diagnostics, 11.","DOI":"10.3390\/diagnostics11101796"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1080\/09553002.2021.1956007","article-title":"The cardiac toxicity of radiotherapy\u2014A review of characteristics, mechanisms, diagnosis, and prevention","volume":"97","author":"Wei","year":"2021","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_31","first-page":"216","article-title":"Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions","volume":"16","author":"Banfill","year":"2021","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaccao.2020.07.005","article-title":"Characterization of Immune Checkpoint Inhibitor-Related Cardiotoxicity in Lung Cancer Patients From a Rural Setting","volume":"2","author":"Moey","year":"2020","journal-title":"JACC. CardioOncology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"102282","DOI":"10.1016\/j.ctrv.2021.102282","article-title":"Pathophysiology, diagnosis and management of cardiac toxicity induced by immune checkpoint inhibitors and BRAF and MEK inhibitors","volume":"100","author":"Arangalage","year":"2021","journal-title":"Cancer Treat. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Gernaat, S.A., I\u0161gum, I., de Vos, B.D., Takx, R.A., Young-Afat, D.A., Rijnberg, N., Grobbee, D.E., van der Graaf, Y., de Jong, P.A., and Leiner, T. (2016). Automatic Coronary Artery Calcium Scoring on Radiotherapy Planning CT Scans of Breast Cancer Patients: Reproducibility and Association with Traditional Cardiovascular Risk Factors. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0167925"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.amjcard.2009.09.005","article-title":"Relation of coronary artery calcium score to premature coronary artery disease in survivors >15 years of Hodgkin\u2019s lymphoma","volume":"105","author":"Andersen","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-0029-1214386","article-title":"Impact of disease duration on coronary calcification in patients with acromegaly","volume":"117","author":"Herrmann","year":"2009","journal-title":"Exp. Clin. Endocrinol. Diabetes Off. J. Ger. Soc. Endocrinol. Ger. Diabetes Assoc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2174\/1570161116666180117111856","article-title":"Mandatory Reporting of Coronary Artery Calcifications Incidentally Noted on Chest Multi-Detector Computed Tomography: A Multicentre Experience","volume":"17","author":"Cappabianca","year":"2019","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.radonc.2015.01.006","article-title":"Coronary calcium score in 12-year breast cancer survivors after adjuvant radiotherapy with low to moderate heart exposure\u2014Relationship to cardiac radiation dose and cardiovascular risk factors","volume":"114","author":"Tjessem","year":"2015","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/jamaoncol.2021.1144","article-title":"Identification of Risk of Cardiovascular Disease by Automatic Quantification of Coronary Artery Calcifications on Radiotherapy Planning CT Scans in Patients With Breast Cancer","volume":"7","author":"Gal","year":"2021","journal-title":"JAMA Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00380-020-01611-2","article-title":"Chemoradiation therapy for non-small cell lung cancer exacerbates thoracic aortic calcification determined by computed tomography","volume":"35","author":"Miki","year":"2020","journal-title":"Heart Vessel."},{"key":"ref_41","first-page":"173","article-title":"Predictive value of vascular calcification identified in 4D planning CT of lung cancer patients treated with stereotactic body radiation therapy","volume":"78","author":"Abravan","year":"2020","journal-title":"Phys. Med. PM Int. J. Devoted Appl. Phys. Med. Biol. Off. J. Ital. Assoc. Biomed. Phys. (AIFB)"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijrobp.2021.08.017","article-title":"Coronary Artery Calcifications and Cardiac Risk after Radiotherapy for Stage III Lung Cancer","volume":"112","author":"Wang","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clinimag.2015.07.002","article-title":"Role of computed tomography screening for detection of coronary artery disease","volume":"40","author":"Han","year":"2016","journal-title":"Clin. Imaging"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ehjci\/jeaa351","article-title":"Cardiac computed tomography in cardio-oncology: An update on recent clinical applications","volume":"22","author":"Rosmini","year":"2021","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1038\/s41467-021-23235-4","article-title":"Deep learning predicts cardiovascular disease risks from lung cancer screening low dose computed tomography","volume":"12","author":"Chao","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijrobp.2009.10.010","article-title":"Baseline cardiopulmonary function as an independent prognostic factor for survival of inoperable non-small-cell lung cancer after concurrent chemoradiotherapy: A single-center analysis of 161 cases","volume":"79","author":"Semrau","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"932044","DOI":"10.3389\/fcvm.2022.932044","article-title":"Atrial Cardiomyopathy Predicts Worse Outcome in Patients With Lung Cancer","volume":"9","author":"Ren","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"730","DOI":"10.5603\/KP.a2015.0071","article-title":"Assessment of risk factors for mortality in patients with cardiovascular disease and a history of treatment for malignancy","volume":"73","author":"Rydzek","year":"2015","journal-title":"Kardiol. Pol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/3\/400\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:13:15Z","timestamp":1760119995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/3\/400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,22]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["diagnostics13030400"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics13030400","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,22]]}}}